Nucleic acid compositions related to MIR-138-1-3P and uses thereof
US9890382B2 · kind B2 · utility
1Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2017 |
| Grant date | Feb 13, 2018 |
| Priority date | — |
| Expiry date | May 4, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.